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ABSTRACT 
CARBON NANOTUBE THIN FILM TRANSISTORS FOR 
BIOMEDICAL APPLICATIONS 
Vanessa Velasco 
August 5, 2010 
The application of carbon nanotubes (CNTs) has captivated the curiosity of 
today's experts due to the escalating potential in the field of electronic detection of 
biomolecules. Their extreme environmental sensitivity and small size make them ideal 
candidates for future biosensing technologies. Recent studies have shown that the 
binding of receptor proteins (biomolecules located at the membrane of cells) with their 
corresponding antibodies immobilized on a carbon nanotube surface causes changes in 
the electrical properties of carbon nanotubes and have been measured with a carbon 
nanotube field effect transistor (CNTFET). This specific molecular interaction and 
sensitivity is promising for the direct detection of live cells in blood. 
In this study, a biosensor was developed based on carbon nanotube thin film 
transistors for the purpose of electrically detecting breast cancer cells (MCF-7) in blood. 
The electrical response of specific and non-specific interactions between anchored 
antibodies onto the carbon nanotube film surface and breast cancer cells mixed with 
iv 
blood were monitored and recorded. The electrical measurements indicate that devices 
functionalized with specific antibodies (anti-IGFIR) experience large conductivity drops 
(-60 %). However for those device printed with non-specific antibodies (anti-IgG), small 
changes (-10 %) in conductivity are measured. It is postulated that the addition of 
increasing number of MCF-7cells mixed with blood on a CNT surface functionalized 
with specific antibodies (anti-IGFIR) acts as a chemical gate modulating the current 
flow. Biosensing mechanistic studies using a liquid gated CNTFET, confirmed that the 
specific antibody-receptor binding can be attributed to electrostatic gating effect by 
which cancer cells can be screened in blood. 
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Carbon nanotubes (CNTs) have been the cornerstone of many research projects 
since their discovery by Japanese physicist, Sumio Iijima in 1991 [1]. Owing to their 
unique structure, mechanical, and electrical properties, they have been proposed for many 
applications. One of the most interesting carbon nanotubes applications is the electrical 
detection of biomolecules and biomolecular interactions for the development of new 
biosensors and biosensing techniques. 
The electrical detection or monitoring of biomolecules has been accomplished by 
integrating carbon nanotubes, particularly, single-walled carbon nanotubes (SWCNTs) 
into field effect transistors (FETs) to form sensor platforms [2]. In these electrical 
devices, carbon nanotubes play the role of transducers by translating biological 
interactions into characteristic electrical signals. Upon the binding of electrically charged 
target molecules to ligands linked to the CNT surface, the device experiences a change in 
conductance [3]. Consequently, if specific biological interactions such as those that 
occur in malignant diseases are studied and characterized through carbon nanotubes field 
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effect transistors (CNTFETs), new low-cost and portable bio-analytical platforms would 
emerge. 
In the past, CNTFETs have been used for the detection of various biological 
species such as proteins, DNA hybrids, viruses, bacteria and other analytes alike [4-7]. In 
this project, we developed thin film transistors to detect human breast cancer cells (MCF-
7) mixed in blood. This was accomplished though the implementation of a technique that 
involves receptor proteins binding to their corresponding antibodies. Carbon nanotubes 
were functionalized with antibodies specific to cancer cell surface markers. At the onset 
of molecular interactions, the carbon nanotubes experience changes in their electronic 
properties which were measured by the CNTFETs. In the following, the motivation, the 
contributions of this research and a general overview of the thesis are presented. 
1.1 Motivation 
The spontaneous appearance of circulating tumor cells (CTCs) in the bloodstream 
is a signal of invasive behavior of cancer cells. The detection of such cancer cells has the 
possibility of providing a tool for cancer prognosis, diagnosis of minimal residual 
disease, evaluation of tumor sensitivity to anticancer drugs, and personalized cancer 
therapy and management [8]. As a result, the early diagnosis of invasive cancers could 
be possible with highly sensitive and specific detection of CTCs. 
The motivation of this thesis id to develop innovative biomedical devices to detect 
cancer cells stems from the limitations of current diagnostic tools. Current methods in 
biomolecular detection have lengthy tum-over times, laborious sample purification 
procedures, and lack the sensitivity and specificity for single analyte screening [9]. The 
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electronic detection of biomolecules has shown the potential of becoming an effective 
alternative to conventional optical bio-detection methods [10]. Therefore, in order to 
address the problem, novel and cost-effective biomedical nano-devices such as CNTFET-
based biosensors need to be studied and developed in order to achieve selective cancer 
detection. 
1.2 Contributions bv the Research 
This work focuses on the design of biosensors based on an array of CNT thin film 
transistors to detect human breast cancer cells (M CF -7) mixed in blood. The biosensors 
designed use specific ligands (antibodies) functionalized on the surface of the CNTs to 
target physiological cancer surface markers. A biosensing mechanism that involves 
electrostatic interactions and charge transfer between CNTs and antibody-cell surface 
receptor binding is used to determine the specific biological interactions using carbon 
nanotube-based devices. The electrostatic interactions induce changes in the electrical 
properties of the CNTs, which were readily measured by the CNT thin film transistors. 
1.3 Overview ofthe Thesis 
This thesis is divided In five chapters. The first chapter presents a brief 
introduction and motivation of the research. The basic background of the present work is 
discussed in Chapter 2, which include a brief description on breast cancer cells, cancer 
surface markers, carbon nanotubes and why their integration in field-effect transistors 
holds the potential for the detection of cancer cells in blood. Chapter 3 includes the 
design and fabrication of biosensors based on CNT thin film transistors. Chapter 4 
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focuses on the experimental results obtained and discussion of such results. Finally, 
conclusions and future work are presented in Chapter 5. 
4 
CHAPTER 2 
CARBON NANOTUBE TRANSISTORS FOR BIOSENSING 
APPLICATIONS 
Recent discoveries in the field of cancer biology have achieved a better 
understanding of cancer surface markers (receptor proteins located on the surface of 
cancer cells). However, utilizing this biological information to develop relevant cancer 
diagnostic methods remains a difficult task. In order to address this challenge, in this 
work, CNT thin film transistors were developed to electronically detect human breast 
cancer cells in blood. Before continuing any further, it is necessary to present a basic 
background of the investigation. From herein, a brief description of circulating tumor 
cells, breast cancer cells MCF-7 and cancer surface markers are presented. Furthermore, 
carbon nanotubes and their properties are discussed, as well as, CNT functionalization 
methods. Lastly, carbon nanotube field-effect transistors and their biomedical 
applications are summarized. 
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2.1 Circulating Tumor Cells 
Circulating tumor cells (CTCs) are cells that escape from a primary tumor site, 
travel in the bloodstream to a secondary site and begin to form a new tumor, causing 
metastasis. Metastasis is the spread of cancer from its initial location to other places in 
the body (see Figure 2.1-a) [11]. According to studies, circulating breast cancer cells are 
more frequently detected at advanced clinical stages rather than at early stages of disease 
[12]. The late detection ofCTCs has been correlated to lethal metastases, one of the main 
factors that lead to cancer treatment failure. It was reported that women with primary 
breast cancer were screened for disseminated tumor cells (DTC; similar to CTC) found in 
bone marrow. Several years later, a check-up indicated that - 30 % of the women who 
tested positive for DTCs had larger number of deaths cases caused by cancer than those 
women who tested negative for DTCs [13-14]. As a result, the early detection of CTCs 
has the potential of playing critical role in future cancer diagnostic and management 
methods. 
The detection of CTCs in peripheral blood has remained a challenge till this day. 
This is due to their low concentration compared to other components found in blood. It 
has been reported that a patient with metastatic cancer only has - 1 to 10 CTCs mixed 
with 10 million leukocytes and 5 billion erythrocytes in 1 mL of blood [15]. Moreover, 
distinguishing CTCs from normal epithelial cells and leukocytes also poses a great task. 
Techniques for CTCs screening have been proposed including immuno-cytometry, 
immuno-magnetic and reverse transcriptase polymerase chain reaction (RT-PCR) [16]. 
However, these usually require laborious sample preparation procedures. 
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Figure 2.1-a Illustration of metastasis, when a cancer cell leaves the tumor site and enters 
the blood stream and moves to a secondary location to form a new tumor site [17]. 
2.2 Breast Cancer Cells (MCF-7) 
MCF-7 is a breast cancer cell line. Figure 2.2-a depicts an image ofMCF-7 cells. 
It was first isolated in 1970 from a patient with metastatic breast cancer [18]. MCF-7 is a 
great model for cancer research because it is one of the most used and best characterized 
of all human breast cancer cell lines. Additionally, this cell line can be used to study 
malignant progression. Work by Bullinger et ai, showed that under appropriate 
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endocrinologic and physiologic pressures, variants of MCF-7 with more advanced 
phenotypes are observed [19]. 
Figure 2.2-b A fluorescent microscopy image and optical microscope image ofMCF-7 
cells [20]. 
2.3 Cancer Surface Markers 
Cancer surface markers are receptor proteins located at the membrane of a 
specific cancer cell type. Receptor proteins (IGF 1 Rand HER2) bind specifically to their 
respective antibodies (anti-IGF1R and anti-HER2) versus binding to non-specific 
antibodies such as IgG. (see Figure 2.3-a) [21]. Advances in cancer biology has lead to 
the identification of membrane proteins of cultured breast cancer cell line MCF -7 and has 
been discovered that insulin-like growth receptor (IGF1R) and human epithelial growth 
factor receptor 2 (HER2) are overexpressed by breast cancer cells [22-25]. Studies have 
indicated that MCF-7 cells express IGF1R at higher levels than other known human 
breast cancer cell lines [22]. Consequently, the use IGFIR antibodies to target IGFIR 
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proteins and detect circulating breast cancer cells hold incredible potential for the 
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Figure 2.3-a An illustration ofIGFlR antibodies binding to IGFIR proteins at surface of 
cell membrane [26]. 
2.4 Carbon Nanotubes 
Owing to the novel properties that carbon nanotubes exhibit, they are excellent 
candidates as tranducing elements in biosensors. Carbon nanotubes are graphene sheets 
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seamlessly wrapped into cylindrical tubes, with nano-scaled diameters often 
acknowledged for having extremely high aspect ratios compared to other materials. It 
has been reported that typical diameters of SWCNT range between OA nm to 2 nm, while 
their lengths can be up to 1.5 cm [27]. CNTs come in two forms multi-walled or single-
walled. Single-walled carbon nanotubes (SWCNTs) consist of a one atom thick planar 
sheet of carbon atoms organized a honeycomb crystal lattice, while multi-walled carbon 
nanotubes (MWCNTs) are composed of several layers of graphene sheets (Figure 2A-a). 
In the context of this project, when CNTs are discussed, it will be referring to SWCNTs. 
D D 
SWCNT MWCNT 
Fh:ure 2.4-a Schematic representation of the SWCNT, MWCNT and the aspect ratio 
parameters for a carbon nanotube [28]. 
The structure of SWCNT is usually described by the chiral vector (Ch), which is 
shown in Figure 2A-b. The chiral vector depends on a pair of integers (n,m). These 
integers express the relative position of the atoms in a graphene strip when they are rolled 
onto each other to form the tube. When integers n=m, the carbon nanotubes have an 
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"armchair" configuration. When n or m=O, carbon nanotubes have a "zig-zag" 
configuration. Any other configuration is denoted as chiral [1]. 
The chirality of CNTs has been linked to their electrical behavior. Armchair 
nanotubes present metallic behavior, zig-zag nanotubes are semiconducting and chiral 
nanotubes can be metallic or semiconducting depending on the diameter of the tube and 
wrapping angle [29-30]. 
A. B. 
ztg-zag atnlchair chiral 
Figure 2.4-b (A) Graphene honeycomb network with lattice vectors al and a2. The chiral 
vector represents the possible wrapping of the 2D graphene sheet into a tubular form. 
The direction perpendicular to Ch is the tube axis. (B) The 3 different configurations of 
CNTs [31]. 
Carbon nanotubes are composed of Sp2 bonds which are stronger than Sp3 bonds 
found in diamonds. In carbon nanotubes, three out of the four electrons found in the 
outer shell of carbons participate in the bonding with neighboring carbons. The fourth 
electron is located in the p-orbital perpendicular to the hexagonal lattice. These p-orbital 
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electrons are distributed in the valence (n) and conduction (n *) energy levels [32]. These 
levels are separated by an energy band gap (Eg). The energy band gap is representative 
of the amount of energy it takes to free an electron and become a mobile charge carrier. 
The value of the band gap is indicative of the electrical conductivity behavior of the 
nanotube. In the case of insulating CNTs, the band gap is larger than ~ 5 eV [33]. 
Semiconducting nanotubes have slightly lower energy band gaps while metallic 
nanotubes have no gap between the conduction and valence bands. The nanotube's 
diameter plays an important role in their electrical behavior as well. According to Heller 
et ai, nanotubes with smaller diameters usually have larger band gaps [34]. 
Additionally, the position of the Fermy energy is yet another parameter used for 
the classification of CNTs as metallic or semiconducting. For undoped carbon 
nanotubes, the EF is at the charge neutrality point (ErO). However, when the carbon 
nanotube undergoes electron (n) or hole (p) doping the EF shifts up or downward. When 
Fermi level shifts exceed the energy separation between subbands, a semiconducting 
nanotube becomes metallic [35]. 
One of the most interesting properties of SWCNTs, especially for biosensing 
applications, is the fact that all their atoms lie at the surface and have the ability to 
participate in electrostatic interactions. CNTs are extremely sensitive to their 
environment. The presence of any external substance causes changes in their electrical 
properties. Thus, SWCNTs have the ability for highly sensitive detection of 
biomolecules through the depletion or accumulation of charge carriers caused by the 
binding of molecules at the surface [36]. 
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2.5 Antibodv Functionalization of Carbon Nanotubes 
The immobilization of antibodies over the surface of the carbon nanotubes is 
fundamental in the development of a biosensor. In the past, antibodies have been 
functionalized either by covalent or non-covalent attachment methods [37]. In this 
project, a non-covalent approach was used for the immobilization of IGFIR, HE2 and 
IgG antibodies on the surface of the CNTs. Covalent methods provide chemical stability 
and functionality; yet have been shown to hamper electrical and mechanical properties of 
SWCNTs [37-38]. Non-covalent attachment, although not as robust as covalent 
immobilization, preserves the electrical and mechanical properties of carbon nanotubes 
[39]. 
Investigations show that supramolecular forces play a significant role in the 
physical adsorption of proteins (such as antibodies) onto CNTs [40]. Hydrophobic 
interactions are one of the major sources of carbon nanotube and protein binding [41]. 
Protein surfaces with high degree of hydrophobicity display a stronger affinity to the 
surface. On the same note, an increased protein adsorption is also observed when the 
surface is more hydrophobic [40-42]. 
2.6 Carbon Nanotube Field-Effect Transistors (CNTFETs) 
CNTFETs are electronic devices where the conduction of current occurs along the 
surface of carbon nanotubes [2]. Figure 2.6-a showcases an illustration of a typical 
CNTFET. It consists of three electrodes denoted as the source, drain and gate. Voltage 
is applied to both the source and gate electrode, while the drain electrode is held at 
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ground. The application of a voltage on the gate electrode produces an electric field that 
alters the amount of current that travels through the conducting channel. 
There are two main gate electrode configurations used for biosensing with 
CNTFETs: a "back" gated architecture and an electrolyte (or liquid) gated architecture. 
Back gated CNTFETs are those which the gate terminal is located on back of the 
substrate (usually silicon) as presented in Figure 2.6-a. In this architecture, a silicon 
oxide layer (or other dielectric material) acts as an insulator between the Si substrate and 
SWCNTs. When a voltage is applied to the back gate, an electric field is produced across 
the dielectric layer. By modifying the electric field, the density of mobile charges on the 
SWCNTs can also be altered. 
Electrolyte gated transistors function in a liquid environment. For electrolyte 
gated CNTFETs, solution containing an analyte is placed in direct contact with the 
SWCNTs and a probe is inserted into the liquid, as shown in Figure 2.6-a. The 
electrochemical potential of the solution is controlled with the gate voltage [42]. When a 
gate voltage is applied, the interface of CNT -electrolyte solution becomes polarized. As 
a result, the double layer forms a gate capacitance, which can be large [35]. This type of 
experimental setup can be ideal for biosensing. Resulting from the facts that most 
biological processes take place in liquid environments and real time molecular interaction 
can be observed [43]. Moreover, KrUger et ai, and Rosenblatt et ai, have demonstrated 
that highly performing CNTFETs were achieved through electrolyte gating [35, 43]. 
The performance of a CNTFET for detecting applications is usually described by 
the transfer characteristic (or device characteristic, DC) of the device [9]. This is the 
amount of current that flows between the drain and source as a result of the application of 
14 
different gate voltages (V g) at a fixed source-drain voltage (Vsd). It is typically displayed 
as a current versus gate voltage plot (see Figure 2.6-b). Another way that transistor 
performance is expressed derives from the DC and it is referred as the ON/OFF current 
ratio. The ON/OFF ratio is attained by dividing the current at the peak of the DC and 
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Silicon substrate. 
Figure 2.6-a Schematic of a typical (A) back gated CNTFET and its components. (B) a 
liquid gated CNTFET where a probe is interested into a liquid and used as a gate 
terminal [41] . 
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Figure 2.6-b A diagram of the transfer characteristic of a p-type CNTFET with both back 
gate and liquid gate configurations. The solid line is the performance of the device 
measure in air and the dashed line is the performance of the device in water [44]. 
Similar to silicon based FETs, CNTFETs display n-type or p-type behavior. N-
type CNTFETs are those that at negative gate voltages conduct little to no current and are 
said to be at the "OFF" state. While, at positive gate voltages, electrons flow more easily 
and the transistor is said to be at the "ON" state. P-type CNTFETs, on the other hand, 
behave in the opposite manner. At negative gate voltages, they are at an "ON" state, but 
are "OFF" at positive voltages. In normal ambient conditions, CNTFETs behave mostly 
as p-type transistors [45]. This is due to the fact CNTs are doped with oxygen molecules 
when exposed to air. N-type behavior in CNTFETs has also been observed, but only 
when they have been subjected to chemical doping. Reports have indicated that 
adsorption of electron-donating molecules or charge transfer from alkali metals lead to n-
type CNTFETs [46]. 
A parameter that influences the performance of a CNTFET is the Schottky barrier 
(SB). The SB is the rectifying barrier at the interface of the metal electrode and CNT. It 
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represents the mismatch in the energy position of the majority carrier band edge of the 
CNT and the metal's Fermi level across the interface. Usually the CNT and metal have 
different work functions. Therefore a donation of electrons from the metal to the 
partially depleted valence band of the CNT occurs when equilibrium at the Fermi level is 
achieved [47]. The SB reduces the transport of holes from the metal electrode to the 
valence band of the SWCNT at positive gate voltages. This leads to a small current flow 
and the device is in the "OFF" state. At more negative gate voltages, the SB increases 
the hole transport into SWNCT. Consequently, the flo~ of current increases and the 
device is in the "ON" state [2]. 
Two different types of CNTFETs have been developed and studied. One consists 
of a single SWCNT anchored between the source and drain electrodes. This type of 
device is very sensitive displaying ON/OFF current ratios of several orders of magnitudes 
[48]. Despite their outstanding performance, single CNTFET are not practical for mass 
production. There is significant performance discrepancies between devices resulting 
from variability of chirality and diameter of the nanotube used. Furthermore, the 
Schottky barrier varies substantially from device to device [10]. 
The second type of CNTFET consists of a network (or film) of CNTs operating as 
the conducting channel, as shown in Figure 2.6-c. Carbon nanotubes in a typical network 
usually consist of a mixture of semiconducting and metallic nanotubes. Nonetheless, new 
approaches in CNT synthesis and filtration have made it possible to produce CNT soots 
with 99 % of either metallic or semiconducting CNTs. For the CNTFETs fabricated in 
this project, the CNT thin film was composed of both semiconducting (70 %) and 
metallic (30 %) CNTs. Hence, for the sake of not loosing focus on this thesis, from 
17 





Figure 2.6-c CNTFETs based on (A) a single CNT and (B) a network (film) of CNTs. 
Inserts are AFM scans that illustrate the topography of the devices [10]. 
Carbon nanotube thin film devices consisting of a mixture of metallic and 
semiconducting CNTs tend to be less sensitive but are more reproducible than single 
CNT devices. Their overall performance depends on the collective properties of each 
carbon nanotube. Thus, the density of the CNTs plays a critical role on how the device 
behaves. For example, in dense CNT films, metallic CNTs tend to screen the gate 
voltage and lower the ON/OFF ratio of the device [46] . In thin CNT film devices, 
percolation issues increase the ON/OFF ratio. Hu et al. explains that in low density 
networks, there are only a small amount of paths for current to flow and the possibility of 
those paths being non-continuous is high. This can lead to higher ON/OFF ratios than 
those observed for thick films [49]. 
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2.7 CNTFETs for Biomedical Applications 
For years now, CNTFETs have been proposed for many biosensing applications. 
In CNTFETs, a current flows through the surface of the nanotube structure and is in 
direct contact with the environment. Therefore, at the occurrence of any changes in the 
proximity of the CNT surface, a change can be measured in the devices' transfer 
characteristic. 
When a molecule approaches the CNT surfaces, four main phenomena can take place: 
electrostatic gating, Schottky barrier effect, reduced gating efficiency, or reduced carrier 
mobility (scattering effect) [49-50]. However, the most reported biosensing mechanisms 
have been those of electrostatic gating and scattering effects. Charge transfer involves 
the molecule donating a hole or an electron to the CNT. The device characteristic shifts 
toward more positive gate voltage when the molecule donates a hole and shifts toward 
more negative gate voltages when an electron is donated (see Figure 2.7-a). 
Alternatively, scattering effects due to the presence of the molecules cause a decrease in 
mobility. In this case, the DC shifts downward as seen in Figure 2.7 -a. This type of 




Figure 2.7-a Transfer characteristic of (a) charge transfer between biomolecule and CNT 
and (b) scattering effects caused by the presence of molecules [10]. 
In the past, CNTFETs have been used to detect a large range of biomolecules 
such as glucose, proteins like IgG, DNA, and viruses, among others [3-6]. In 2008, Ning 
Shao reported the detection of CTCs in blood using a field effect transistor composed of 
small bundle CNTs [51]. Although, he successfully showed the detection of a single 
CTC in blood, single and small bundle CNTFETs are difficult to reproduce making them 
ineligible for mass production. Carbon nanotube thin films transistors on the other hand 
are easily fabricated and tend to behave more consistently from film to film. Carbon 
nanotube thin films transistors have not been used yet in the detection of CTCs. Thus, in 
the present work, thin film carbon nanotube field effect transistors were developed for the 
purpose of detecting breast cancer cells (MCF-7) in whole blood. 
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CHAPTER 3 
METHODS AND MATERIALS 
In this chapter, a comprehensive description of the materials, reagents, equipment, 
and protocols utilized during the development and testing of the CNTFET based 
biosensor are discussed. The experimental approach, CNTFET fabrication and 
functionalization methods, as well as, biomolecule detection are presented. This chapter 
provides a detailed procedure that can be utilized to reproduce the findings of this 
document, while offering a foundation for future developments. 
3.1 Experimental Approach 
In the present research, an array of CNT thin films transistors was developed for 
the detection of circulating breast cancer cells in blood. Although single CNTFETs have 
shown to be more sensitive, CNTFETs based on CNT thin films offer some advantages. 
They are easier to fabricate and reproduce and have more surface area for biomolecule 
immobilization and target binding. During the course of the project, two designs were 
implemented. The first design consisted of a large CNT thin film (with a surface area of 
~ 4mm2) anchored between two chromium (Cr)/ gold (Au) electrodes separated by a gap 
of ~ 1 mm as in Figure 3.I-a. In this design, a back silicon gate configuration was used. 
These devices were functionalized with three different antibodies (specific and 
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non-specific) and the interaction of 5 )lL of blood mixed with different MCF -7 cells 
concentrations was examined. 
Figure 3.1-a An image of the wafer containing the array of the first design of CNTFETs. 
A total of 12 devices were fabricated in a single substrate. The inset is an SEM image of 
a single device. 
A second design of CNTFETs was manufactured in order to investigate the 
sensing mechanisms and gain a better understanding of the phenomena that occurs during 
CTCs screening with the CNT thin film devices mentioned above (refer to Figure 3.1-b). 
For this design, a localized liquid gate configuration was utilized to modulate the current 
in the conducting channel. According to Dekker et ai, insight on sensing mechanisms 
can be achieved by observing the effects of protein adsorption or binding on the 
conductance of the device at different liquid gate potentials [50]. These CNTFETs were 
scaled down to a smaller film area of ~0.008 mm2 with only ~ 100 )lm gap between 
patterned electrodes in order to observe any charge transfer and minimize diffusive 
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behavior of charged particles. A more detailed description regarding the biosensor 
structure, antibody functionalization methods and electrical characterization is provided 
below for both biosensors. 
Figure 3.1-b An image of a chip with an array ofthe electrolyte gated devices presented 
in this research. 
3.2 CNTFET-based Biosensor Architecture 
The structures of both CNTFET-based biosensors are presented in Figure 3.2-a. The 
biosensor consists of a silicon oxidized substrate used as both an insulator (in the case of 
the oxide) and back gate (in the case of the silicon). A semiconducting channel was 
formed by a patterned thin CNT film, located on top of the dielectric film. Two metal 
electrodes separated by ~ 1 mm gap for the first design and ~ 100 !lm gap for the second 
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design that act as the drain and source and anchor the thin CN T film. A localized liquid 
gate consisting of 1 JlL of - lOmM NaCl solution that sits on top of the nanotube 
conducting channel. Finally, a SU-8 layer was deposited to isolate the electrodes from 












Figure 3.2-a Schematic illustration of both biosensor designs based on CNTFETs. (A) 
First design consisting of a large CNT film anchored between two electrodes at a distance 
of - 1 mm. (B) Second design used for sensing mechanistic studies by applying a liquid 
gate potential. A smaller CNT film area is anchored between two electrodes set to - 100 
Jlm apart. 
3.3 Fabrication ofCNTFET-based Biosensor 
A batch fabrication process was used for both designs. An advantage of batch 
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fabrication is that multiple testing can be conducted on a single substrate while 
concurrently limiting large fluctuations in device electrical characteristics. 
Transistor fabrication consisted of three different lithography steps and a metal 
deposition step. A 4" n-type doped silicon substrate was used as a platform to build the 
biosensors. A ~500 nm thick oxide is grown by thermal oxidation. The substrate was 
then placed in the MARCH RIE system for an oxygen plasma clean. Treating surfaces 
with O2 plasma has been known to change the surface energy and improve the wettability 
of a surface [52] . 
A carbon nanotube solution was prepared from commercially obtained single wall 
carbon nanotubes dispersed in isopropyl alcohol to a concentration of ~O.007mg/ml. The 
solution was placed in an ultrasonication bath for ~ 24 hours to separate the highly 
entangled SWCNTs into individual or small bundle SWCNTs (refer to Figure 3.3-a). 
Fieure 3.3-a Images of (A) CNT soot, (B) undispersed CNT solution and (C) dispersed 
CNT solution. 
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A vacuum filtration process was used to produce the carbon nanotube thin films. 
30 mL of the dispersed CNT solution was vacuum filtered through a Millipore mixed 
cellulose ester (MCE) membrane. The CNT film was then transferred and bonded to a 
silicon oxide substrate by a procedure reported previously [53]. After vacuum filtration, 
the wet CNT film and membrane were transferred onto the silicon oxide substrate and 
subjected to compressive loading between two heavy flanges (cushioned by porous filter 
paper) for ~ 20min. During compressive loading, the CNT film and membrane dries and 
adheres to the substrate. The MCE membrane is then dissolved by placing the wafer/ .. 
nanotube/membrane composite in an acetone vapor bath. The condensed acetone washes 
the membrane off, leaving a wrinkle free CNT film on the substrate. 
The CNT film thickness was controlled by the CNT solution concentration and 
volume used during vacuum filtration. Figure 3.3-b illustrates different CNT films 
attained from two different concentrations. In this work, visibly transparent thin films 
were produced for the biosensor as shown in Figure 3.3-b. 
After the CNT film was thoroughly rinsed and baked to remove any residual 
impurities, the film was patterned. Defining the carbon nanotube conducting channel was 
accomplished by photolithography and a successive step of O2 plasma etching in an 
inductively coupled plasma system (ICP), as explained in Shaoxin Lu et ai, and Ashkan 
Behnam et ai, work [54-55]. A 2.7/lm thick photoresist and photolithography were used 
to mask the desired resulting pattern. The thickness choice of photoresist layer was 
important since the O2 plasma etching does not selectively etch the carbon nanotubes and 
also removes the photoresist. The ICP system was set to a power of 200 W, bias power 
of 100 Wand 02 flow rate of 50 sccm, resulting in an etch rate of ~ 5.4nmls. After 
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etching, the substrate is gently washed with acetone, methanol, and isopropyl alcohol to 
remove the etching mask and remove any other impurities resulting from the 
photolithography process. The etching process produces anisotropic etch profiles 
necessary for carbon nanotube integration in microfabricated devices. 
Figure 3.3-b Images of CNT films of different thicknesses. (A) A dense CNT film while 
(B) is a thinner film. The ultra thin film was used in this research. 
A second lithography step defined the metal electrodes for the source and drain. 
The substrates were prepared for metal deposition by applying a 1.3 )lm thick positive 
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photoresist (Shipley 1813) and carrying out standard photolithography steps. A 
chromium film of ~ 1 0 nm was deposited as an adhesion layer followed by ~ 1 00 nm 
biocompatible gold film. The polymer and metal that did not pertain to the electrodes 
was lifted off by placing the substrate in an acetone bath. Following, the substrate was 
rinsed with isopropyl alcohol and then dried with nitrogen. Finally, a 2 J..lm thick SU8 
layer was added and patterned only exposing the carbon nanotube area between the 
electrodes to the environment. The SU8 layer helped to isolate the electrodes from the 
biomolecules and solutions and limit the possibility of any unwanted reactions or noise. 
3.4 CNT Film Characterization 
CNT characterization is usually accomplished through different mIcroscopy 
methods. In this present work, Scanning Electron Microscopy (SEM) and Atomic Force 
Microscopy (AFM) were used to analyze the CNT films. SEM and AFM scans as in 
Figure 3.4-a were used to determine the topography and density of CNT network, verify 
the presence and coverage of antibodies on the CNT surface. During SEM imaging a 
maximum voltage of 10 kV was used for bare CNT films. For biomolecule 
functionalized CNT, a range of 2 to 6 kV was used. Finally, a working distance of 5-
15mm was used at all times. AFM scans were performed by Ben King, a lab mate in the 
small systems laboratory. He was able to image bare CNTs as well as antibody coated 
CNTs. 
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Figure 3.4-a (A) An SEM image of bare CNT film. (B) An AFM scan of the interface 
between uncoated and antibody coated antibodies. 
3.5 Electrolyte Solution Preparation 
For the CNTFET-based biosensors, a liquid gate configuration was used in the 
mechanistic studies for the detection of cancer cells in blood. In the past, Rosenbaltt et 
ai, has reported on high performing electrolyte gated transistors and stated that a NaCL 
solution was used for most of their experiments [43] . Therefore, a - I OmM NaCL 
solution was prepared and used as the liquid gate in the experiments executed in this 
research. 
3.6 Blood Sample Preparation 
Blood samples were obtained from a healthy male collaborator in Thomas 
Jefferson University. MCF-7 cells were cultured at Thomas Jefferson University as well. 
Samples were prepared by mixing the cultured cell with blood at different concentrations. 
29 
Samples were sent and arrived the same day. Experiments were performed upon the 
arrival of samples. 
3. 7 Antibodv Functionalization 
A non-covalent approach was implemented for the immobilization of antibodies 
onto the surface of the CNT film. The functionalization process was as follows: 
commercially purchased antibodies were diluted in phosphate buffered saline (PBS) to a 
concentration of - 10 IlgimL. A 5 ilL (for large CNT film transistors) and 1 ilL (for 
mechanistic study transistors) droplet of antibody solution was placed onto the surface of 
the CNT film and incubated for 3 min at room temperature, allowing the molecules to 
diffuse down to the surface and bond with the CNTs. Then the surface was flushed with 
PBS. At this point, the large CNT film transistors were ready for an electrical 
measurement. For the liquid gated transistors, a droplet of NaCI was placed on the CNT 
surface for electrical measurement. The transfer characteristic was taken and the surface 
was ready for the blood sample mixed with breast cancer cells. Then, a 5 ilL (for large 
CNT film transistors) or 1 ilL (for mechanistic study transistors) drop of blood was 
placed on the surface allowed to settle for 3 min and then it was removed, rinsed, and 
another electrical measurement was taken. Physical adsorption of the antibodies and 
blood with CTCs was driven by hydrophobic interactions between the random network of 
CNTs and antibodies [40]. 
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3.8 Electrical Characterization 
The CNTFETs were electrically characterized with an Agilent 4156 precision 
semiconductor parameter analyzer and probe station, as depicted in Figure 3.8-a. The 
source and drain electrodes were probed using gold-coated tips. The gold tips were used 
to avoid any corrosive reaction during the liquid gating. After probing the device, a 
resistance measurement was performed by applying a source-to-drain voltage (V sd) and 
sweeping from -IV to IV, while keeping the gate voltage (V g) at a value of O. At the 
same time, the source-to-gate current or leakage current (Isg) was monitored. After these 
initial measurements were completed, 1 ilL of electrolyte solution was placed on the CNT 
surface and the gate probe was immersed into the droplet. Next, the baseline of the 
device characteristic was recorded by sweeping the gate voltage (Vg) and holding the Vsd 
at a constant value. This was executed again after antibody functionalization and after 
exposure of blood. 
The flow of current through the conducting channel at the addition of antibodies 
and blood was also recorded. These experiments were performed by once again probing 
the source and the drain. Then, a fixed Vsd was applied and the source-to-drain current 
(Isd) was measured with respect to time. To initiate run, the device was allowed to 
stabilize for two minutes, then a 1 ilL drop of antibody or blood was added to CNT 
surface. Another three minutes was allowed to elapse and a second drop would be added. 
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Figure 3.8-a An image of the device during experimental measurements. The devices 
were placed in a probing station and probes with gold coated tips. 
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CHAPTER 4 
RESUL TS AND DISCUSSION 
The application of carbon nanotube thin films transistors for the detection of 
circulating breast cancer cells was achieved by incorporating CNT thin films into an 
electrical device configuration, functionalizing monoclonal antibodies on the surface of 
the carbon nanotube networks and monitoring the electrical signatures during interaction 
of blood mixed with breast cancer cells on carbon nanotube networks. 
4.1 Biosensor Design Parameters 
Preliminary evaluations indicated that the performance of the CNT thin film 
transistor was dependent on the CNT film thickness. As a result, the electrical 
characterization of several devices with an assortment of CNT densities was completed. 
Experiments indicated that thicker films displayed a metallic behavior and required 
significantly large gate voltage (V g > 30V) in order to create an electric field that would 
modulate the current. This is in accordance to previous observations performed by Hu et 
aI, where he attributed low ON/OFF current ratios of dense films to conductive CNT that 
act to screen the gate voltage [49]. As a result, ultra thin films were used for the 
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construction of the biosensors. An AFM scan of the CNT film determined a thickness of 
~ 180 nm for the film. 
4.2 Antibody Functionalization 
Monoclonal antibodies were functionalized onto the surface of CNT film through 
physical adsorption. The physical adsorption is attributed to hydrophobic interactions 
between CNTs and antibodies as previous reported by Allen et ai, [42]. Figure 4.2-a 
shows the contrasting behavior of the hydrophobic interactions of a drop of blood and 
antibody between a CNT film and silicon oxide surface. 
Figure 4.2-a Image depicting the hydrophobic interactions of a drop of blood and 
antibody between a CNT film and silicon oxide surface. 
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The density and uniformity of the immobilized antibodies over the CNT film was 
investigated with the use SEM and AFM imaging. Three different concentrations namely 
I f.lg/mL, 5 f.lg/mL, and 10 f.lg/mL and three different volumes namely 1 f.lL, 5 f.lL, and 10 
f.lL were used in an array and imaged using AFM and SEM. Figure 4.2-b shows the 
representative images of the antibodies on the surface of carbon nanotube films . From 
the images, a uniform coating was noticed for 5 f.lL of antibody solution of ~ 1 0 llg/mL. 
As a result, a dose 5 f.lL of antibody solution at a concentration of ~ 10 f.lg/mL was used 
for detection circulating breast cancer cells in blood. 
Figure 4.2-b AFM and SEM images of a uniform coating of 5 ilL antibodies. 
4.3 Detection Circulating Breast Cancer Cells with CNT Thin Films 
The electrical response (I vs. V ds) of thin CNT films functionalized with different 
antibodies (specific and non-specific) were recorded after adding 5 f.lL of blood mixed 
with 1-300 MCF-7 breast cancer cells. Upon adding biological components, a noticeable 
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change in conductance was observed, as shown in Figure 4.3-a. The reduction in 
conductance was negligible for PBS wash. However, a 50 % drop in the current of the 
device was observed after the adsorption of 5 ilL of anti-HER2. After antibody 
adsorption, the addition of blood mixed with cancer cells also resulted in an additional 
decrease in device conductance. 
Comparison studies between the electrical behaviors of CNT thin films 
functionalized with specific (anti-IGFIR) and non-specific (anti-IgG) antibodies were 
conducted in order to investigate whether sensitive and specific detection of molecular 
surface receptors is possible in a sample of unaltered blood. 5 III ofanti-IGFIR and anti-
IgG were immobilized on the surface of the CNT networks followed by the addition of 
blood with different MCF-7 cell concentrations. Figure 4.3-b shows that devices printed 
with IgG experiences less than a ~ 1 0% change in conductivity while devices printed 
with IGFIR exhibits ~60 % drop in conductivity with increasing number of MCF-7 
breast cancer cells in blood. Taking a closer look, the electrical characteristics attained 
from IGFIR are similar to that of a field effect transistor, where the increasing 
concentration of cancer cells act as a chemical gate modulating the current flow between 
source and drain. The binding of IGFIR receptor proteins to their respective antibodies 
reduces the charge carrier concentration in the carbon nanotubes which leads to a 
reduction in the conductivity of the device. Similar results were also observed by Li et 
ai, and his colleagues in University of Southern California where they detected prostate-
specific antigen using In203 nanowires and carbon nanotubes [56-57]. 
The distinguished drop in conductivity for specific antibody and receptor 
interactions can be further observed from a real time current measurement of 
36 
functionalized CNT film transistor with anti-IGFIR upon the addition of a blood control 
sample and blood mixed with MCF-7 cells, as shown in Figure 4.3-c. 
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Figure 4.3-a A change in the current flow through CNT conducting channel is observed 
after functionalizing the CNT film, with antibodies and the current is further reduced 
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Figure 4.3-b Portrays the difference of device behavior between specific and non-
specific binding. IgG is a non-specific protein and it shows minimal changes in 
conductance. On the other hand, IGFIR, a specific protein receptor found in breast 
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Figure 4.3-c Displays real time current measurements upon the addition of 5 ilL blood 
control sample and a blood sample that contained MCF-7 cells_ 
4.4 Mechanistic Studies 
In order to understand the phenomena occurring in the biosensors based CNT thin 
film transistors above, mechanistic studies were carried out with liquid gated CNTFETs. 
The goal of these experiments was to identify the interactions between the CNTs and the 
antibody-receptor binding that lead to the charge carriers being reduced. 
The transfer characteristics (I vs. V g) of liquid gated transistors were monitored 
upon the addition of 1 ilL of antibodies and 1 ilL MCF -7 cells mixed with blood in order 
to identify the electrostatic interactions taking place between CNTs and the binding of 
surface receptors with antibodies. For these experiments, only one single concentration 
ofMCF-7 cells (5 MCF-7 cells/ ilL) of blood was used. 
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The transfer characteristics were recorded for devices functionalized with IgG and 
IGFIR antibodies as shown in Figure 4.4-a. It can be observed that there is a distinct 
difference between electrical characteristics of non-specific and specific interactions of 
MCF-7 surface receptors. For the device printed with IGFIR antibodies, there is obvious 
shift in the threshold voltage (~250 mY), whereas a device printed with anti-IgG has no 
distinguishable shift. Biosensing mechanistic studies performed by Dekker's group, 
indicate that the adsorbed charged species induced a partial charge transfer between the 
carbon nanotubes and biomolecules [50]. Thus, CNT is doped and leads to a shift in the 
1- V g curve. In the case of the results attained in this project, the threshold voltage shift 
towards more negative gate voltages originates from an electron donation to the CNTs 
when the binding of IGFIR receptor to immobilized ligands take place. However, the 
biosensing mechanism can not only be attributed to gating effect. From Figure 4.4-a, one 
can observe that the current is also suppressed after adding the blood mixed with cancer 
cells. Current suppression is often observed when the CNTs experience mechanical 
distortion [10]. In the context of this project, it is thought that the current suppression is 
caused by the blood medium. Several components in blood can cause stress on the 
functionalized surface and minimize the mobility of charge carries. 
The transfer characteristic corresponding to non-specific IgG interactions with 
breast circulating cancers is one that is similarly observed for a change in charge mobility 
as explained by Kauffman et ai, (refer to Figure 4.4-a) [2]. As the circulating cancer cells 
and blood components approach the functionalized CNT surface, they inhibit the 
acceleration of electrons causing collisions and scattering effects. Similarly to those 
caused by impurities in semiconductors. 
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Figure 4.4-a Comparison of transfer characteristics upon adding a 1 JlL drop of 5 MCF-7 
celV JlL of blood (A) a device functionalized with non-specific IgG antibodies and (B) 
device functionalized with specific antibodies IGF 1 R antibodies . 
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CHAPTERS 
CONCLUSIONS AND FUTURE WORK 
In conclusion, the preliminary results from this research indicate that the detection 
of circulating breast cancer cells in blood medium may be possible using biosensors 
based on CNT thin film transistors. By functionalizing the surface area of the CNT film 
with ligands that specifically bind to surface receptors on breast cancer cells, specific 
protein interaction can be detected on the surface of the CNTs. Owing to the sensitivity 
of CNTs, the binding of cancer surface markers to their respective antibodies participate 
in a charge transfer with the CNTs whereas non-specific interactions do not. Further 
investigations are required for future implementation of such detection technique, such as 
control experiments with blood containing no cancer cells and other cancer cell types. As 
well as, fluorescent imaging to confirm the immobilization of cancer cells on CNT 
surface. Nonetheless, the detection of biomolecules with carbon nanotube thin film 
sensors based on transistors shows great promise for selective detection of biomolecules 
that can be implemented into relevant biosensors. 
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